192 related articles for article (PubMed ID: 8941580)
1. Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function.
Jacobson SH; Lu Y; Brauner A
Nephrol Dial Transplant; 1996 Nov; 11(11):2209-14. PubMed ID: 8941580
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-6 receptor, interleukin-10 and granulocyte colony-stimulating factor in acute pyelonephritis: relationship to markers of bacterial virulence and renal function.
Jacobson SH; Lu Y; Brauner A
Nephron; 1998 Dec; 80(4):401-7. PubMed ID: 9832638
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function.
Jacobson SH; Hylander B; Wretlind B; Brauner A
Nephron; 1994; 67(2):172-9. PubMed ID: 7915403
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
[TBL] [Abstract][Full Text] [Related]
5. Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.
Olszyna DP; Prins JM; Buis B; van Deventer SJ; Speelman P; van der Poll T
Infect Immun; 1998 Aug; 66(8):3527-34. PubMed ID: 9673230
[TBL] [Abstract][Full Text] [Related]
6. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
7. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
[TBL] [Abstract][Full Text] [Related]
8. Cytokine antagonists in aged subjects and their relation with cellular immunity.
Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.
van der Poll T; Fischer E; Coyle SM; Van Zee KJ; Pribble JP; Stiles DM; Barie PS; Buurman WA; Moldawer LL; Lowry SF
J Infect Dis; 1995 Aug; 172(2):577-80. PubMed ID: 7622910
[TBL] [Abstract][Full Text] [Related]
11. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
Sikora JP; Kuzański W; Andrzejewska E
Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
[TBL] [Abstract][Full Text] [Related]
12. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
13. Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria.
Hedges S; Stenqvist K; Lidin-Janson G; Martinell J; Sandberg T; Svanborg C
J Infect Dis; 1992 Sep; 166(3):653-6. PubMed ID: 1500753
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
[TBL] [Abstract][Full Text] [Related]
16. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentration of cytokine antagonists in patients with infection following liver resection.
Kimura F; Miyazaki M; Suwa T; Sugiura T; Shinoda T; Itoh H; Ambiru S; Shimizu H; Nakagawa K
Br J Surg; 1998 Dec; 85(12):1631-5. PubMed ID: 9876064
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
19. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
[TBL] [Abstract][Full Text] [Related]
20. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection.
Edén CS; Hanson LA; Jodal U; Lindberg U; Akerlund AS
Lancet; 1976 Sep; 1(7984):490-2. PubMed ID: 74461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
